Prognosis of patients with residual pathological disease after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy and surgery for esophageal squamous cell carcinoma: a retrospective cohort study.
Mashiro OkunakaDaisuke KotaniHisashi FujiwaraKazuma SatoNaoto FujiwaraSaori MishimaShingo SakashitaTakayuki YoshinoTakeo FujitaTakashi KojimaPublished in: Therapeutic advances in medical oncology (2024)
In this largest-to-date cohort study, patients with residual pathological disease after neoadjuvant DCF followed by surgery for locally advanced ESCC had a poor prognosis. In these patients, pathological node positivity, including supraclavicular lymph node metastasis, and lymphovascular invasion were considered significant prognostic factors.
Keyphrases
- prognostic factors
- lymph node metastasis
- poor prognosis
- minimally invasive
- lymph node
- locally advanced
- rectal cancer
- coronary artery bypass
- long non coding rna
- squamous cell carcinoma
- end stage renal disease
- papillary thyroid
- newly diagnosed
- chronic kidney disease
- surgical site infection
- stem cells
- radiation therapy
- peritoneal dialysis
- patient reported outcomes
- endometrial cancer
- cell migration
- percutaneous coronary intervention
- bone marrow
- atrial fibrillation